Successful outcomes with Biovera products start long before the first injection. A thorough pre-procedure protocol protects both the patient and the physician, while maximizing the therapeutic benefit.

Patient Assessment

• Comprehensive medical history, including allergies and current medications
• Review of previous aesthetic treatments and outcomes
• Skin analysis under standardized lighting
• Clear identification of the patient's primary concern and treatment goals
• Realistic expectation setting with the patient

Contraindications to Screen

• Active skin infection or inflammation in the treatment area
• Known hypersensitivity to any component of the product
• Pregnancy or breastfeeding
• Autoimmune conditions affecting the skin
• Recent use of certain medications (to be evaluated by the physician)

Pre-Treatment Preparation

• Stop retinoids 5–7 days before treatment (if applicable)
• Avoid blood-thinning medications as advised by the physician
• No alcohol 24 hours before the procedure
• Ensure the patient is well-hydrated
• Take pre-procedure photographs for documentation

Documentation

Biovera products are supplied with self-adhesive labels with batch numbers for treatment documentation. Saudi clinics should maintain complete records in line with SFDA requirements and SCFHS professional standards.

On the Day

• Confirm the patient identity and the product batch
• Disinfect the treatment area thoroughly
• Use the recommended needles for each technique (30G ½", 30G 13mm, 27G 4mm)
• Inject slowly and according to the approved protocol

For full protocol training in Saudi Arabia, contact the Biovera scientific support team.